Carlisle (CSL) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 8, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Jul 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CSL SEC filings page.
Carlisle (CSL) reported $5.1B in revenue over the twelve months to Jun 30, 2026, up 1.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Cash generation remains durable while buybacks and debt reshaped Carlisle’s balance sheet more than its nearly flat revenue did.
The 2025 earnings reset did not produce a comparable cash reset: net income fell to$741M , while operating cash flow reached$1.1B . Compared with FY2024, when net income exceeded operating cash flow by roughly$281M , this suggests reported profit has been more volatile than the underlying cash economics.
The business is not currently capital-hungry: 2025 capital spending was
Short-term liquidity improved, but the longer-term capital structure became more leveraged. Debt-to-equity reached 1.6x from 0.8x in FY2024, while 2025 included
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Carlisle's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Carlisle has an operating margin of 20.0%, meaning the company retains $20 of operating profit per $100 of revenue. This strong profitability earns a score of 87/100, reflecting efficient cost management and pricing power. This is down from 22.9% the prior year.
Carlisle's revenue grew a modest 0.3% year-over-year to $5.0B. This slow but positive growth earns a score of 48/100.
Carlisle has a moderate D/E ratio of 1.60. This balance of debt and equity financing earns a leverage score of 38/100.
With a current ratio of 3.09, Carlisle holds $3.09 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 80/100.
Carlisle converts 19.3% of revenue into free cash flow ($970.6M). This strong cash generation earns a score of 86/100.
Carlisle earns a strong 41.3% return on equity (ROE), meaning it generates $41 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 84/100. This is down from 53.3% the prior year.
Carlisle scores 5.09, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Carlisle passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Carlisle generates $1.49 in operating cash flow ($1.1B OCF vs $740.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Carlisle earns $12.77 in operating income for every $1 of interest expense ($1.0B vs $78.5M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Carlisle generated $1.6B in revenue in Q2 2026. This represents an increase of 8.3% from the same quarter a year earlier. Against the prior quarter it is up 49.3%.
Carlisle's EBITDA was $401.2M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 4.5% from the same quarter a year earlier. Against the prior quarter it is up 74.8%.
Carlisle reported $255.2M in net income in Q2 2026. This represents a decrease of 0.2% from the same quarter a year earlier. Against the prior quarter it is up 99.8%.
Carlisle earned $6.30 per diluted share (EPS) in Q2 2026. This represents an increase of 7.1% from the same quarter a year earlier. Against the prior quarter it is up 103.2%.
Cash & Balance Sheet
Carlisle generated $200.1M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 22.5% from the same quarter a year earlier. Against the prior quarter it is up 374.1%.
Carlisle held $665.3M in cash against $2.9B in long-term debt as of Q2 2026.
Carlisle paid $1.10 per share in dividends in Q2 2026. This represents an increase of 10.0% from the same quarter a year earlier. It is unchanged from the prior quarter.
Margins & Returns
Carlisle's gross margin was 36.2% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 1.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.7 percentage points.
Carlisle's operating margin was 22.4% in Q2 2026, reflecting core business profitability. This is down 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.3 percentage points.
Carlisle's net profit margin was 16.3% in Q2 2026, showing the share of revenue converted to profit. This is down 1.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.1 percentage points.
Carlisle's ROE was 15.8% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 3.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 8.1 percentage points.
Capital Allocation
Carlisle invested $11.4M in research and development in Q2 2026. This represents an increase of 2.7% from the same quarter a year earlier. Against the prior quarter it is down 5.8%.
Carlisle spent $250.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 16.7% from the same quarter a year earlier. It is unchanged from the prior quarter.
Carlisle invested $41.7M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 44.8% from the same quarter a year earlier. Against the prior quarter it is up 47.3%.
CSL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.6B+8.3% | $1.1B-4.0% | $1.1B+0.4% | $1.3B+1.0% | $1.4B-0.1% | $1.1B-0.1% | $1.1B-0.4% | $1.3B+5.9% |
| Cost of Revenue | $1.0B+10.3% | $688.9M-3.0% | $747.1M+4.1% | $861.7M+5.2% | $908.4M+3.0% | $710.1M+1.8% | $717.4M | $819.2M+3.2% |
| Gross Profit | $568.4M+5.0% | $363.2M-5.8% | $380.6M-6.1% | $485.2M-5.7% | $541.1M-4.9% | $385.7M-3.3% | $405.5M-3.4% | $514.4M+10.4% |
| R&D Expenses | $11.4M+2.7% | $12.1M+13.1% | $12.9M+46.6% | $12.4M+53.1% | $11.1M+19.4% | $10.7M+16.3% | $8.8M | $8.1M+12.5% |
| SG&A Expenses | $199.3M+1.2% | $171.8M-11.4% | $176.6M+1.0% | $177.9M-7.2% | $196.9M+4.0% | $194.0M+16.3% | $174.9M | $191.8M+18.6% |
| Operating Income | $352.5M+5.2% | $180.3M-1.8% | $190.0M-15.2% | $293.9M-7.1% | $335.0M-11.3% | $183.6M-18.5% | $224.0M-11.7% | $316.4M+5.5% |
| EBITDA | $401.2M+4.5% | $229.5M-0.8% | $240.0M-11.1% | $343.7M-4.8% | $383.9M-8.7% | $231.4M-12.4% | $270.0M | $361.0M+3.1% |
| Interest Expense | $27.4M+86.4% | $28.3M+91.2% | $27.7M+60.1% | $21.3M+14.5% | $14.7M-21.8% | $14.8M-20.4% | $17.3M | $18.6M-4.1% |
| Income Tax | $76.0M+11.6% | $35.5M+1.7% | $39.0M-1.5% | $64.3M-14.2% | $68.1M-22.1% | $34.9M-20.5% | $39.6M | $74.9M+12.5% |
| Net Income | $255.2M-0.2% | $127.7M-10.9% | $127.4M-21.7% | $214.2M-12.3% | $255.8M-64.1% | $143.3M-25.5% | $162.8M-20.8% | $244.3M-8.0% |
| EPS (Basic) | $6.33+6.7% | $3.12-3.4% | $3.11-17.3% | $5.02-5.5% | $5.93-60.5% | $3.23-19.7% | $3.76-11.5% | $5.31-0.7% |
| EPS (Diluted) | $6.30+7.1% | $3.10-3.1% | $3.09-16.9% | $4.98-5.1% | $5.88-60.4% | $3.20-19.4% | $3.72-11.4% | $5.25-0.8% |
| Diluted Shares (Avg) | 41M-6.7% | 41M-8.1% | N/A | 43M-7.7% | 43M-9.4% | 45M-7.6% | N/A | 47M-7.2% |
CSL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.2B+13.0% | $6.0B+9.9% | $6.3B+7.7% | $6.5B-0.3% | $5.5B-18.0% | $5.5B-18.0% | $5.8B-12.1% | $6.5B-5.0% |
| Current Assets | $2.3B+50.4% | $2.0B+32.7% | $2.3B+18.2% | $2.5B-14.7% | $1.5B-51.6% | $1.5B-55.8% | $1.9B-43.5% | $2.9B-20.4% |
| Cash & Equivalents | $665.3M+872.7% | $771.3M+250.3% | $1.1B+47.6% | $1.1B-27.8% | $68.4M-96.1% | $220.2M-60.2% | $753.5M+30.7% | $1.5B+1317.2% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $492.7M-1.6% | $481.0M-9.2% | $447.3M-5.4% | $481.4M+4.1% | $500.9M+17.5% | $529.6M+32.5% | $472.7M+30.7% | $462.4M+17.1% |
| Accounts Receivable | $955.9M+8.4% | $692.1M-1.0% | $593.8M+2.4% | $774.3M-3.1% | $881.7M-2.4% | $699.4M-0.2% | $579.7M-5.8% | $799.2M+4.0% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $1.5B+0.3% | $1.5B+3.2% | $1.5B+4.1% | $1.5B+14.0% | $1.5B+14.8% | $1.5B+24.2% | $1.5B+22.9% | $1.3B+13.9% |
| Total Liabilities | $4.6B+35.9% | $4.3B+32.0% | $4.5B+33.2% | $4.5B+20.2% | $3.4B-8.7% | $3.3B-13.3% | $3.4B-11.5% | $3.7B-4.5% |
| Current Liabilities | $883.4M+26.7% | $601.3M+1.4% | $736.0M+10.5% | $764.7M-28.4% | $697.1M-36.0% | $593.1M-49.5% | $665.8M-43.9% | $1.1B+22.0% |
| Non-Current Liabilities | $3.7B+38.2% | $3.7B+38.8% | $3.7B+38.9% | $3.7B+39.8% | $2.7B+2.6% | $2.7B+3.0% | $2.7B+3.2% | $2.6B-12.2% |
| Long-Term Debt | $2.9B+52.5% | $2.9B+52.5% | $2.9B+52.7% | $2.9B+52.5% | $1.9B+0.2% | $1.9B+0.2% | $1.9B0.0% | $1.9B-17.3% |
| Total Equity | $1.6B-23.7% | $1.7B-23.7% | $1.8B-27.1% | $2.0B-27.9% | $2.1B-29.4% | $2.2B-24.2% | $2.5B-12.9% | $2.8B-5.5% |
| Retained Earnings | $7.6B+7.6% | $7.4B+7.9% | $7.3B+8.3% | $7.3B+8.9% | $7.1B+9.7% | $6.9B+18.8% | $6.8B+20.2% | $6.7B+21.7% |
CSL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $241.8M-15.8% | -$44.7M-2583.3% | $386.0M+4.2% | $426.9M+36.5% | $287.1M+56.5% | $1.8M-98.9% | $370.6M-4.7% | $312.8M-29.2% |
| Depreciation & Amortization | $48.7M-0.4% | $49.2M+2.9% | $50.0M+8.7% | $49.8M+11.7% | $48.9M+13.5% | $47.8M+22.9% | $46.0M | $44.6M-11.3% |
| Stock-Based Compensation | N/A | $8.5M-20.6% | N/A | N/A | N/A | $10.7M-10.8% | N/A | $8.0M+5.3% |
| Capital Expenditures | $41.7M+44.8% | $28.3M-2.4% | $39.9M+9.0% | $33.5M+73.6% | $28.8M+15.7% | $29.0M-10.8% | $36.6M+1.9% | $19.3M-46.7% |
| Free Cash Flow | $200.1M-22.5% | -$73.0M-168.4% | $346.1M+3.6% | $393.4M+34.0% | $258.3M+63.0% | -$27.2M-120.8% | $334.0M-5.4% | $293.5M-27.6% |
| Investing Cash Flow | -$41.7M+52.1% | -$28.0M+64.5% | -$41.0M+85.3% | -$33.5M-89.3% | -$87.0M-105.6% | -$78.9M-146.6% | -$279.3M-163.6% | -$17.7M+42.5% |
| Financing Cash Flow | -$305.8M+13.2% | -$268.0M+41.3% | -$338.3M+61.0% | $643.5M+228.4% | -$352.5M+38.8% | -$456.4M-174.8% | -$867.3M-144.2% | -$501.0M+24.9% |
| Dividends Paid | $44.4M+3.0% | $45.7M+1.1% | $45.8M+1.8% | $47.0M+2.4% | $43.1M+6.9% | $45.2M+8.9% | $45.0M+9.8% | $45.9M+8.8% |
| Share Buybacks | $250.0M-16.7% | $250.0M-37.5% | $300.0M-28.5% | $300.0M-35.6% | $300.0M-45.5% | $400.0M+166.7% | $419.8M+31.2% | $466.1M+41.2% |
CSL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 36.2%-1.1pp | 34.5%-0.7pp | 33.8%-2.4pp | 36.0%-2.5pp | 37.3%-1.9pp | 35.2%-1.2pp | 36.1%-1.1pp | 38.6%+1.6pp |
| Operating Margin | 22.4%-0.7pp | 17.1%+0.4pp | 16.9%-3.1pp | 21.8%-1.9pp | 23.1%-2.9pp | 16.8%-3.8pp | 20.0%-2.5pp | 23.7%-0.1pp |
| Net Margin | 16.3%-1.4pp | 12.1%-0.9pp | 11.3%-3.2pp | 15.9%-2.4pp | 17.6%-31.5pp | 13.1%-4.5pp | 14.5%-3.7pp | 18.3%-2.8pp |
| Return on Equity | 15.8%+3.7pp | 7.7%+1.1pp | 7.1%+0.5pp | 10.8%+1.9pp | 12.1%-11.7pp | 6.6%-0.1pp | 6.6%-0.6pp | 8.8%-0.2pp |
| Return on Assets | 4.1%-0.5pp | 2.1%-0.5pp | 2.0%-0.8pp | 3.3%-0.4pp | 4.6%-6.0pp | 2.6%-0.3pp | 2.8%-0.3pp | 3.8%-0.1pp |
| Current Ratio | 2.60+0.4x | 3.38+0.8x | 3.09+0.2x | 3.25+0.5x | 2.19-0.7x | 2.58-0.4x | 2.890.0x | 2.73-1.5x |
| Debt-to-Equity | 1.78+0.9x | 1.74+0.9x | 1.60+0.8x | 1.45+0.8x | 0.89+0.3x | 0.87+0.2x | 0.77+0.1x | 0.68-0.1x |
| Asset Turnover | 0.250.0x | 0.180.0x | 0.180.0x | 0.210.0x | 0.260.0x | 0.200.0x | 0.190.0x | 0.210.0x |
| FCF Margin | 12.7%-5.1pp | -6.9%-4.5pp | 30.7%+1.0pp | 29.2%+7.2pp | 17.8%+6.9pp | -2.5%-14.4pp | 29.7%-1.6pp | 22.0%-10.2pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Carlisle CSL | FY2025 | $5.0B | $740.7M | 14.8% | $13.6B | 71/100 |
| Builders Firstsource Inc BLDR | FY2025 | $15.2B | $435.2M | 2.9% | $7.1B | 47/100 |
| Masco MAS | FY2025 | $7.6B | $810.0M | 10.7% | $14.3B | 61/100 |
| Lennox International LII | FY2025 | $5.2B | $805.8M | 15.5% | $13.5B | 63/100 |
| Owens Corning OC | FY2025 | $10.1B | -$522.0M | -5.2% | $11.0B | 52/100 |
| Advanced Drain Sys Inc Del WMS | FY2026 | $3.1B | $429.0M | 14.1% | $10.2B | 67/100 |
Where Carlisle Ranks
Frequently Asked Questions
What is Carlisle's annual revenue?
Carlisle (CSL) reported $5.0B in total revenue for fiscal year 2025. This represents a 0.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Carlisle's revenue growing?
Carlisle (CSL) revenue grew by 0.3% year-over-year, from $5.0B to $5.0B in fiscal year 2025.
Is Carlisle profitable?
Yes, Carlisle (CSL) reported a net income of $740.7M in fiscal year 2025, with a net profit margin of 14.8%.
What is Carlisle's EBITDA?
Carlisle (CSL) had EBITDA of $1.2B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Carlisle have?
As of fiscal year 2025, Carlisle (CSL) had $1.1B in cash and equivalents against $2.9B in long-term debt.
What is Carlisle's gross margin?
Carlisle (CSL) had a gross margin of 35.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Carlisle's operating margin?
Carlisle (CSL) had an operating margin of 20.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Carlisle's net profit margin?
Carlisle (CSL) had a net profit margin of 14.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Carlisle pay dividends?
Yes, Carlisle (CSL) paid $4.20 per share in dividends during fiscal year 2025.
What is Carlisle's return on equity (ROE)?
Carlisle (CSL) has a return on equity of 41.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Carlisle's free cash flow?
Carlisle (CSL) generated $970.6M in free cash flow during fiscal year 2025. This represents a 5.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Carlisle's operating cash flow?
Carlisle (CSL) generated $1.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Carlisle's total assets?
Carlisle (CSL) had $6.3B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Carlisle's capital expenditures?
Carlisle (CSL) invested $131.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Carlisle spend on research and development?
Carlisle (CSL) invested $47.1M in research and development during fiscal year 2025.
What is Carlisle's current ratio?
Carlisle (CSL) had a current ratio of 3.09 as of fiscal year 2025, which is generally considered healthy.
What is Carlisle's debt-to-equity ratio?
Carlisle (CSL) had a debt-to-equity ratio of 1.60 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Carlisle's return on assets (ROA)?
Carlisle (CSL) had a return on assets of 11.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Carlisle's P/E ratio?
Carlisle (CSL) trades at 18.7x earnings, its market capitalization divided by net income of $724.5M net income, trailing 12 months to June 30, 2026. The market capitalization is $13.6B as of Sep 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Carlisle's price-to-sales ratio?
Carlisle (CSL) trades at 2.7x sales, its market capitalization divided by revenue of $5.1B revenue, trailing 12 months to June 30, 2026. The market capitalization is $13.6B as of Sep 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Carlisle's Altman Z-Score?
Carlisle (CSL) has an Altman Z-Score of 5.09, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Carlisle's Piotroski F-Score?
Carlisle (CSL) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Carlisle's earnings high quality?
Carlisle (CSL) has an earnings quality ratio of 1.49x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Carlisle cover its interest payments?
Carlisle (CSL) has an interest coverage ratio of 12.77x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Carlisle?
Carlisle (CSL) scores 71 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.